The University of Manchester Cancer Research Centre in the UK has announced a 1.35 million pound investment to accelerate brain tumor research at one of the UK’s leading research universities. They have pledged funding to support the appointment of the first Chair of Neuro-Oncology Translational Science at the university’s Cancer Research Centre.
This newly-created role will enhance Manchester’s reputation as a global center for neuro-oncology services and research following the recent opening of the UK’s first NHS proton beam therapy machine at The Christine Hospital.
The Function: Unite Groups; Attract Talent and Funding
The Chair will be busy uniting groups working in neuro-oncology and neuro-immunology, as well as in attracting world-leading researchers and scientists to Manchester.
About the University of Manchester Cancer Research Centre
This active research institution was established in 2006 by three founding partners: The University of Manchester, Cancer Research UK and the Christine NHS Foundation Trust. Since its creation, the MCRC has widened its reach to drive the forward cancer research in other NHS trusts within Greater Manchester and to link with other cancer-specific funding bodies.Source: The Brain Tumour Charity